Evogene narrows focus to AI-driven molecule discovery after major strategic overhaul
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
This study evaluated a difficult-to-treat Crohn's disease patient population
Our clinical data suggests ProLectin-M demonstrated earlier reductions in viral shedding compared with placebo with a favorable safety profile
Iza-bren met both dual primary endpoints, delivering statistically significant and clinically meaningful improvements in progression-free survival
Subscribe To Our Newsletter & Stay Updated